Oncology Central

Viral-gene therapy could improve breast cancer reconstruction surgery outcomes

Researchers have demonstrated that a novel viral gene therapy could protect healthy tissue from the harmful side effects of radiotherapy. The team believe the clinical application could extend to preventing radiotherapy side-effects in women who have had breast reconstruction surgery and spare women a second operation to repair the damage caused by delayed side-effects.

The findings from the study, conducted by researchers from The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust (both London, UK), were recently published in Science Translational Medicine.

In order to appraise the protective features of the viral gene therapy, the team

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.